G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics.
American journal of physiology. Cell physiology April 17, 2023 Gavin P. Schmitz, Bryan L. Roth
G protein-coupled receptors (GPCRs) constitute the largest family of druggable genes in the human genome. Even though perhaps 30% of approved medications target GPCRs, they interact with only a small number of them. Here, we consider whether there might be new opportunities for transformative therapeutics for neuropsychiatric disorders by specifically targeting both known and understudied...
DOI: 10.1152/ajpcell.00397.2022 (opens in new tab)
Full text (opens in new tab)
Humans
Receptors, g-protein-coupled
Signal transduction
Drug discovery
+3